Tri-Lo-Mili Shortage Update: What Patients Need to Know in 2026

If you've been having trouble filling your Tri-Lo-Mili prescription, you're probably wondering: is this actually a shortage? Is the medication being discontinued? When will this get better? You deserve a clear answer, not a runaround. Here's the full picture for 2026.

Current Tri-Lo-Mili Shortage Status (2026)

Tri-Lo-Mili is NOT on the FDA's official Drug Shortages Database as of 2026. The active ingredient combination — norgestimate/ethinyl estradiol (triphasic, low-dose) — does not have a nationwide shortage designation from the FDA or ASHP (American Society of Health-System Pharmacists).

However, that technical status doesn't fully explain what patients are experiencing. Across the country, patients report being told Tri-Lo-Mili is "out of stock" or "on backorder" at their regular pharmacy. This is a real phenomenon — and it has specific causes.

Why Is Tri-Lo-Mili Hard to Find Even Without an Official Shortage?

The root cause goes back to the discontinuation of brand-name Ortho Tri-Cyclen Lo by Janssen Pharmaceuticals. When the brand was pulled from the market, patients were dispersed across multiple competing generics: Tri-Lo-Mili (Aurobindo), Tri-Lo-Sprintec (various), Tri-Lo-Estarylla (Allergan/Alvogen), Tri-Lo-Marzia (Marlex), and Tri-VyLibra Lo. Each pharmacy chain negotiated its own preferred generic contracts.

The result is market fragmentation: a patient prescribed Tri-Lo-Mili may discover their pharmacy only stocks Tri-Lo-Sprintec. Or a pharmacy that usually stocks Tri-Lo-Mili runs out because of a delayed shipment from Aurobindo's manufacturing facility in India. These are localized, short-term disruptions — not a true nationwide shortage — but they feel the same to patients at the pharmacy counter.

History: Has Tri-Lo-Mili Been in Shortage Before?

Norgestimate/ethinyl estradiol has not had a prolonged, nationally designated FDA shortage in recent years. The broader oral contraceptive supply chain has remained relatively stable compared to drugs like ADHD medications or GLP-1 medications. The challenges patients face with Tri-Lo-Mili are primarily related to pharmacy stocking decisions, not manufacturing crises.

In contrast, some other contraceptives have seen genuine shortages. Injectable contraceptives (Depo-Provera), certain IUD brands, and emergency contraceptives have faced supply challenges in recent years. Oral contraceptives in this drug class have generally fared better.

What the ACA Contraceptive Mandate Means for You

Under the Affordable Care Act (ACA), most commercial insurance plans and Medicaid are required to cover FDA-approved contraceptives with no cost-sharing (no copay, no deductible). This applies to generic oral contraceptives including Tri-Lo-Mili and its equivalents. If your plan is refusing to cover Tri-Lo-Mili without a copay, you have the right to appeal — or to request coverage for an equivalent generic.

If your pharmacy's preferred generic is Tri-Lo-Sprintec and your insurance covers it at $0, but your prescription says Tri-Lo-Mili, your insurer may require a prior authorization to switch. Many insurers will waive this if your provider calls or submits documentation of the shortage situation.

What Patients Should Do Right Now

Don't panic — and don't stop your pill. Stopping mid-cycle significantly increases pregnancy risk. Keep taking what you have while you search.

Use medfinder to locate a pharmacy with stock. medfinder calls pharmacies near you on your behalf to find which ones can fill your specific Tri-Lo-Mili prescription.

Contact your prescriber about accepting an equivalent generic. Tri-Lo-Sprintec, Tri-Lo-Estarylla, Tri-Lo-Marzia, and Tri-VyLibra Lo are all the same medication. A quick message through your patient portal is often all that's needed.

Try a different pharmacy type. Mail-order pharmacies and telehealth-connected pharmacies (Nurx, Pandia Health, The Pill Club) typically maintain larger inventories.

Ask your pharmacy to order it. Many pharmacies can special-order Tri-Lo-Mili within 3-5 business days if they don't have it on hand. Ask them to check their wholesaler.

Outlook: Will Tri-Lo-Mili Supply Improve?

The overall supply of norgestimate/ethinyl estradiol tablets is expected to remain stable in 2026. Aurobindo Pharma, the manufacturer of Tri-Lo-Mili, is one of the world's largest generic pharmaceutical producers with manufacturing facilities certified by the FDA. There is no indication of a prolonged disruption.

For a deeper dive into why Tri-Lo-Mili can be hard to find even without a shortage, see our explainer: Why Is Tri-Lo-Mili So Hard to Find?.